1-6 of 6
Bettzy Stephen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma

Mohamed A. Gouda, Bettzy Stephen, Yanyan Tian, Anas Alshawa, Dilichukwu O. Chudy Onwugaje ...
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2024) 7 (4): 247–254.
https://doi.org/10.36401/JIPO-24-3
Published: 01 November 2024
View article titled, A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma
Open the PDF for A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma in another window
Journal Articles

Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies

Jibran Ahmed, Bettzy Stephen, Yali Yang, Evan Kwiatkowski, Chinenye Lynette Ejezie ...
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2024) 7 (2): 73–81.
https://doi.org/10.36401/JIPO-23-16
Published: 02 May 2024
View article titled, Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies
Open the PDF for Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies in another window
Includes: Supplementary data
Journal Articles

Therapeutic Role of Synthetic Lethality in ARID1A -Deficient Malignancies

Kyaw Z. Hein, Bettzy Stephen, Siqing Fu
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2024) 7 (1): 41–52.
https://doi.org/10.36401/JIPO-22-37
Published: 05 February 2024
View article titled, Therapeutic Role of Synthetic Lethality in ARID1A -Deficient Malignancies
Open the PDF for Therapeutic Role of Synthetic Lethality in ARID1A -Deficient Malignancies in another window
Journal Articles

Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors

Zainab Fatima, Abdulrahman Abonofal, Bettzy Stephen
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2023) 6 (2): 91–102.
https://doi.org/10.36401/JIPO-22-27
Published: 02 February 2023
View article titled, Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
Open the PDF for Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors in another window
Journal Articles

Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens

Mingxuan Xu, Coya Tapia, Joud Hajjar, Sharjeel Sabir, Rivka Colen ...
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2021) 4 (2): 45–52.
https://doi.org/10.36401/JIPO-21-5
Published: 14 May 2021
View article titled, Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens
Open the PDF for Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens in another window
Includes: Supplementary data
Journal Articles

Haplotype Analysis of the T-Cell Receptor Beta (TCRB) Locus by Long-amplicon TCRB Repertoire Sequencing

Timothy J Looney, Dzifa Y Duose, Geoffrey Lowman, Elizabeth Linch, Joud Hajjar ...
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2019) 2 (4): 137–143.
https://doi.org/10.4103/JIPO.JIPO_16_19
Published: 27 September 2019
View article titled, Haplotype Analysis of the T-Cell Receptor Beta (TCRB) Locus by Long-amplicon TCRB Repertoire Sequencing
Open the PDF for Haplotype Analysis of the T-Cell Receptor Beta (TCRB) Locus by Long-amplicon TCRB Repertoire Sequencing in another window
Includes: Supplementary data